HeartWare Ltd.

Related Articles

Cardiovascular Surgery

FDA Clears HeartWare Ventricular Assist Device
Australia Approves Ventricular Assist System

Ventricular Assist Devices (VAD)

FDA Clears HeartWare Ventricular Assist Device
FDA to Review HeartWare Ventricular Assist Device in April
Australia Approves Ventricular Assist System
FDA Authorizes Third Patient Allotment for Bridge-to-Transplant Trial
Study Examines Earlier Use of Heart Pumps in Heart Failure Patients
PMA Application Filed for Ventricular Assist System
Bridge-to-Transplant Trial Shows 92 Percent Success
Small BiVAD Used in Emergency Case as Twin, Heart Booster Pumps
FDA Approves Destination Therapy Study for Ventricular Assist System
First U.S. Implant of the HeartWare LVAS Announced

Heart Failure Treatments

FDA Clears HeartWare Ventricular Assist Device
FDA to Review HeartWare Ventricular Assist Device in April
FDA Authorizes Third Patient Allotment for Bridge-to-Transplant Trial
Study Examines Earlier Use of Heart Pumps in Heart Failure Patients
Small BiVAD Used in Emergency Case as Twin, Heart Booster Pumps
FDA Approves Destination Therapy Study for Ventricular Assist System

Clinical Trial/Study

FDA Authorizes Third Patient Allotment for Bridge-to-Transplant Trial
Study Examines Earlier Use of Heart Pumps in Heart Failure Patients
Bridge-to-Transplant Trial Shows 92 Percent Success
FDA Approves Destination Therapy Study for Ventricular Assist System

Cardiology Products

First U.S. Implant of the HeartWare LVAS Announced

General Cardiology

First U.S. Implant of the HeartWare LVAS Announced